Literature DB >> 8725572

Diabetes in minorities: reflections on the medical dilemma and the healthcare crisis.

J R Gavin1.   

Abstract

In summary, diabetes in minorities is clearly on the increase. The complication rates are likewise increasing, contributing to the large burden of health care costs. This is a significant medical dilemma inasmuch as these high-risk populations are among the fastest-growing segments of our society. Fortunately, delay and prevention of complications are now possible, although greater programmatic interventions will be required. The absence of such interventions is a reflection of the dimensions of our health care crisis. What is more, we have such poor insight into the reasons for the higher risks and rates of disease and its complications. This means that a critical step toward resolution of this dilemma is more research.

Entities:  

Mesh:

Year:  1996        PMID: 8725572      PMCID: PMC2376549     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  12 in total

1.  The natural history of impaired glucose tolerance in the Pima Indians.

Authors:  M F Saad; W C Knowler; D J Pettitt; R G Nelson; D M Mott; P H Bennett
Journal:  N Engl J Med       Date:  1988-12-08       Impact factor: 91.245

2.  Variation in the incidence and proportion of diabetes-related amputations in minorities.

Authors:  L A Lavery; H R Ashry; W van Houtum; J A Pugh; L B Harkless; S Basu
Journal:  Diabetes Care       Date:  1996-01       Impact factor: 19.112

3.  Are racial differences in the prevalence of diabetes in adults explained by differences in obesity?

Authors:  T R O'Brien; W D Flanders; P Decoufle; C A Boyle; F DeStefano; S Teutsch
Journal:  JAMA       Date:  1989-09-15       Impact factor: 56.272

4.  Lipids, glucose intolerance and vascular disease: the Framingham Study.

Authors:  P W Wilson; W B Kannel; K M Anderson
Journal:  Monogr Atheroscler       Date:  1985

5.  Differences in basal and poststimulation glucose homeostasis in nondiabetic first degree relatives of black and white patients with type 2 diabetes mellitus.

Authors:  K Osei; D A Cottrell; B Harris
Journal:  J Clin Endocrinol Metab       Date:  1992-07       Impact factor: 5.958

6.  Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

Authors:  E Ferrannini; S M Haffner; B D Mitchell; M P Stern
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

7.  Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.

Authors:  M I Harris; W C Hadden; W C Knowler; P H Bennett
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

8.  Insulin action in black Americans with NIDDM.

Authors:  M A Banerji; H E Lebovitz
Journal:  Diabetes Care       Date:  1992-10       Impact factor: 19.112

9.  Impact of NIDDM on mortality and causes of death in Pima Indians.

Authors:  M L Sievers; R G Nelson; W C Knowler; P H Bennett
Journal:  Diabetes Care       Date:  1992-11       Impact factor: 19.112

10.  Diabetic retinopathy in Mexican Americans and non-Hispanic whites.

Authors:  S M Haffner; D Fong; M P Stern; J A Pugh; H P Hazuda; J K Patterson; W A van Heuven; R Klein
Journal:  Diabetes       Date:  1988-07       Impact factor: 9.461

View more
  3 in total

1.  Policy statements adopted by the Governing Council of the American Public Health Association, November 15, 2000.

Authors: 
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

Review 2.  New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.

Authors:  Karim R Saab; Jessica Kendrick; Joseph M Yracheta; Miguel A Lanaspa; Maisha Pollard; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 10.121

3.  'Analogy-Based Comprehensive Diabetes Education' (ABCDE) Improves Glycemic Control of Diabetic Patients in an Underserved Population: Results of a Retrospective Chart Analysis.

Authors:  Rajagopal V Sekhar
Journal:  Healthcare (Basel)       Date:  2022-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.